Fact Sheet for Healthcare Providers: Emergency Use of multiFiltrate PRO System and multiBic/multiPlus Solutions During the COVID-19 Pandemic

Source: U.S. Food and Drug Administration (FDA). Published: 4/30/2020.
This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Fresenius multiFiltrate PRO System and multiBic/multiPlus Solutions to provide continuous renal replacement therapy to treat patients in an acute care environment during the COVID-19 pandemic.
(PDF)

Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 30, 2020 Category: International Medicine & Public Health Source Type: news